Role of Pseudomonas aeruginosa type III effectors in disease
- 28 February 2009
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Microbiology
- Vol. 12 (1), 61-66
- https://doi.org/10.1016/j.mib.2008.12.007
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The bacterial type VI secretion machine: yet another player for protein transport across membranesMicrobiology, 2008
- Secreted bacterial phospholipase A2 enzymes: better living through phospholipolysisTrends in Microbiology, 2007
- Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxinCellular Microbiology, 2006
- Identification of Superoxide Dismutase as a Cofactor for the Pseudomonas Type III Toxin, ExoUBiochemistry, 2006
- Acquisition and Evolution of theexoULocus inPseudomonas aeruginosaJournal of Bacteriology, 2006
- Modulation of lung epithelial functions by Pseudomonas aeruginosaTrends in Microbiology, 2005
- Type III Secretion Phenotypes of Pseudomonas aeruginosa Strains Change during Infection of Individuals with Cystic FibrosisJournal of Clinical Microbiology, 2004
- Protein secretion systems of Pseudomonas aeruginosa and P. fluorescensBiochimica et Biophysica Acta (BBA) - Biomembranes, 2003
- Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosaCritical Care Medicine, 2002
- Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosaMicrobiology, 2001